These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30537896)

  • 21. Low lateral thoracic site for cardiac implantable electronic device implantation: A viable alternative in patients with limited access options after infected device extraction.
    Liang JJ; Schaller RD; Modi DS; Enriquez A; Supple GE; Cooper JM
    Heart Rhythm; 2017 Oct; 14(10):1506-1514. PubMed ID: 28603001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
    Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
    Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous Obstruction in Asymptomatic Patients Undergoing First Implantation or Revision of a Cardiac Pacemaker or Implantable Cardioverter-Defibrillator: A Retrospective Single Center Analysis.
    Pieper CC; Weis V; Fimmers R; Rajab I; Linhart M; Schild HH; Nähle CP
    Rofo; 2015 Nov; 187(11):1029-35. PubMed ID: 26200569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multilevel Venous Obstruction in Patients with Cardiac Implantable Electronic Devices.
    Czajkowski M; Polewczyk A; Jacheć W; Kosior J; Nowosielecka D; Tułecki Ł; Stefańczyk P; Kutarski A
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399623
    [No Abstract]   [Full Text] [Related]  

  • 25. Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction.
    Sohal M; Williams S; Akhtar M; Shah A; Chen Z; Wright M; O'Neill M; Patel N; Hamid S; Cooklin M; Bucknall C; Bostock J; Gill J; Rinaldi CA
    Europace; 2014 Jan; 16(1):81-7. PubMed ID: 23794614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.
    Jacheć W; Polewczyk A; Segreti L; Bongiorni MG; Kutarski A
    Gerontology; 2021; 67(1):36-48. PubMed ID: 33242867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access.
    Jaroszewski DE; Altemose GT; Scott LR; Srivasthan K; Devaleria PA; Lackey J; Arabia FA
    Ann Thorac Surg; 2009 Jul; 88(1):112-6. PubMed ID: 19559206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Swelling Over Cardiac Implantable Electronic Device Sites: A Multicenter Case Series.
    Pothineni NVK; Bonilla CA; Ebrahim MA; Epstein AE; Garcia-Fernandez FJ; Guzman CE; Joshi H; Nasir JM; Singh A; Supple GE; Schaller RD
    Circ Arrhythm Electrophysiol; 2020 Dec; 13(12):e009253. PubMed ID: 33320698
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
    Polyzos KA; Konstantelias AA; Falagas ME
    Europace; 2015 May; 17(5):767-77. PubMed ID: 25926473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous stenosis and occlusion in the presence of endocardial leads in patients referred for transvenous lead extraction.
    Boczar K; Zabek A; Haberka K; Debski M; Rydlewska A; Musial R; Lelakowski J; Malecka B
    Acta Cardiol; 2017 Feb; 72(1):61-67. PubMed ID: 28597736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and predictors of subclavian vein obstruction following biventricular device implantation.
    Bulur S; Vural A; Yazıcı M; Ertaş G; Özhan H; Ural D
    J Interv Card Electrophysiol; 2010 Dec; 29(3):199-202. PubMed ID: 20890650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantation of cardiac resynchronization therapy devices using three leads by cephalic vein dissection approach.
    Hadjis A; Proietti R; Essebag V
    Europace; 2017 Sep; 19(9):1514-1520. PubMed ID: 28340223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of nitroglycerin for preventing venous spasm during contrast-guided axillary vein puncture for pacemaker or defibrillator leads implantation.
    Duan X; Ling F; Shen Y; Yang J; Xu HY; Tong XS
    Europace; 2013 Apr; 15(4):566-9. PubMed ID: 22848074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central venous occlusion is not an obstacle to device upgrade with the assistance of laser extraction.
    Gula LJ; Ames A; Woodburn A; Matkins J; McCormick M; Bell J; Sink D; McConville J; Epstein LM
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):661-6. PubMed ID: 16008801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.